What is Bruker's free cash flow?

Bruker (BRKR) reported free cash flow of $47M in Q1 2026.

How has Bruker's free cash flow changed year-over-year?

Bruker's free cash flow increased by 20.5% year-over-year, from $39M to $47M.

What is the long-term trend for Bruker's free cash flow?

Over 4 years (2021 to 2025), Bruker's free cash flow has grown at a -31.0% compound annual growth rate (CAGR), from $191.1M to $43.3M.

Bruker BRKR Free cash flow

Free cash flow at other companies

Thermo Fisher ScientificTMO

$816M+126%

DanaherDHR

$1.09B+2.9%

WAT

Waters CorporationWAT

-$42M-118%

Agilent TechnologiesA

$201M+87.9%

TEC

Bio-TechneTECH

——

RevvityRVTY

——

Other financials

Income statement

See full

Revenue$823.4M+2.7%

Gross profit$379.8M-2.9%

Operating income$10.2M-67.9%

Net income$14.4M-17.2%

EPS (diluted)$0.02-81.8%

Balance sheet

See full

Cash & equivalents$137.6M-26.7%

Total debt$1.7B-20.9%

Total equity$2.5B+34.6%

Total assets$6.1B+3.3%

Cash flow

See full

Operating cash flow$71.2M+9.5%

CapEx$24.2M-6.9%

Valuation

See full

Market cap$8.71B-13.2%

Enterprise value$10.25B-14.9%

P/S2.5×-0.4×

Profitability

See full

Gross margin45.3%-3.7pp

Operating margin1.3%-5.0pp

Net margin-0.6%-10.0pp

FCF margin1.5%-3.6pp

Returns & leverage

See full

Return on equity-1%-21.2pp

Debt / equity0.7×-0.5×

Current ratio1.6×0.0×

Where this comes from

Calculated from Bruker’s reported figures.

$71.2Mnet cash from operating−$24.2Mcapital expenditures=$47M

The official record: Bruker’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bruker's free cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Bruker's free cash flow?: Bruker (BRKR) reported free cash flow of $47M in Q1 2026.
How has Bruker's free cash flow changed year-over-year?: Bruker's free cash flow increased by 20.5% year-over-year, from $39M to $47M.
What is the long-term trend for Bruker's free cash flow?: Over 4 years (2021 to 2025), Bruker's free cash flow has grown at a -31.0% compound annual growth rate (CAGR), from $191.1M to $43.3M.